National Heart, Lung, and Blood Institute; Notice of Meeting

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 194 (Thursday, October 8, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 194 (Thursday, October 8, 2026)]
[Notices]
[Page 64384]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20617]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Sickle Cell Disease 
Advisory Committee.
    This will be a virtual meeting and will be open to the public as 
indicated below. Individuals who plan to view the virtual meeting and 
need special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: November 16, 2026.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: Imaging and Clinical Impact on the Eye and Brain in 
Sickle Cell Disease.
    Address: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20892.
    Meeting Link: <a href="https://videocast.nih.gov/watch/d8f60236-bb52-11f1-82c0-124f0a52e769">https://videocast.nih.gov/watch/d8f60236-bb52-11f1-82c0-124f0a52e769</a>.
    Meeting Format: Virtual Meeting.
    Contact Person: Julie A. Panepinto, MD, MSPH, DFO/Executive 
Secretary SCDAC, Division of Blood Diseases and Resources, 31 Center 
Lane, Bethesda, MD 20892, (301) 435-0080, <a href="/cdn-cgi/l/email-protection#4329362f2a266d33222d26332a2d372c032d2a2b6d242c35"><span class="__cf_email__" data-cfemail="076d726b6e622977666962776e69736847696e6f29606871">[email&#160;protected]</span></a>.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes.
    Both printed and electronic copies are requested for the record. 
In addition, any interested person may file written comments with 
the committee by forwarding their statement to the Contact Person 
listed on this notice. The statement should include the name, 
address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: <a href="http://www.nhlbi.nih.gov/meetings/index.htm">www.nhlbi.nih.gov/meetings/index.htm</a>, where an agenda and any 
additional information for the meeting will be posted when 
available.

    Dated: October 5, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-20617 Filed 10-7-26; 8:45 am]
BILLING CODE 4167-05-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>